The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension
Open accessAbstract
We sought to compare the risk of end-stage renal disease (ESRD), ischemic heart event (IHE), congestive heart failure (CHF), cerebrovascular accident (CVA), and all-cause mortality among 470,386 individuals with resistant and nonresistant hypertension (non-RH). Resistant hypertension (60,327 individuals) was subcategorized into two groups: 23,104 patients with cRH (controlled on four or more medicines) and 37,223 patients with uRH (uncontrolled on three or more medicines) in a 5-year retrospective cohort study. Cox proportional hazard modeling was used to estimate hazard ratios adjusting for age, gender, race, body mass index, chronic kidney disease (CKD), and comorbidities. Resistant hypertension (cRH and uRH), compared with non-RH, had multivariable adjusted hazard ratios (95% confidence intervals) of 1.32 (1.27-1.37), 1.24 (1.20-1.28), 1.46 (1.40-1.52), 1.14 (1.10-1.19), and 1.06 (1.03-1.08) for ESRD, IHE, CHF, CVA, and mortality, respectively. Comparison of uRH with cRH had hazard ratios of 1.25 (1.18-1.33), 1.04 (0.99-1.10), 0.94 (0.89-1.01), 1.23 (1.14-1.31), and 1.01 (0.97-1.05) for ESRD, IHE, CHF, CVA, and mortality, respectively. Men and Hispanics had a greater risk for ESRD within all three cohorts. Individuals with resistant hypertension had a greater risk for ESRD, IHE, CHF, CVA, and mortality. The risk of ESRD and CVA were 25% and 23% greater, respectively, in uRH compared with cRH, supporting the linkage between blood pressure and both outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of RH is underscored by the associated risk of adverse outcomes compared with non-RH.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
In the citing paper
“In another study of >400 000 patients, compared with patients without RH, patients with RH had a 32% increased risk of developing end-stage renal disease, a 24% increased risk of an ischemic heart event, a 46% increased risk of heart failure, a 14% increased risk of stroke, and a 6% increased risk of death.29”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240
Self-citationUS trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
Vasan, R. S., Larson, M. G., Leip, E. P., Evans, J. C., O’Donnell, C. J., Kannel, W. B., & Levy, D. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003417 · Cited by 2,098
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–240 of 240
Bajo el impulso del Espíritu Santo: Estructura pneumatológica de la moral cristiana
García, M. V. (2000) · Miscelánea Comillas: Revista de Ciencias Humanas y Sociales
Hypertension and Chronic Kidney Disease – An Unhappy Marriage
Feldman, H. A. (2022) · Physician Assistant Clinics · doi:10.1016/j.cpha.2021.11.003
Value of Routine Screening for Hypertension in Childhood
Flynn, J. T. (2022) · Springer eBooks · doi:10.1007/978-3-319-31420-4_43-2
Mohiuddin, M., Lakhani, M., Khan, R. N., Najam, U., Fatimee, S., & Hassan, N. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22166258
Utilidad de la monitorización domiciliaria de presión arterial en la hipertensión resistente oculta
Barochiner, J. (2022) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/revhospitalbaires.v42i2.173
Causes, Evaluation, and Treatment of Secondary and Resistant Hypertension
Hundemer, G. L. (2022) · Nephrology Self-Assessment Program · doi:10.1681/nsap.00082022
Diagnosis and management of resistant hypertension
Wei, F., Liu, C., & Staessen, J. A. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780198870678.003.0024
ESTRATÉGIAS ATUAIS PARA A PREVENÇÃO E O TRATAMENTO DA HIPERTENSÃO
Almeida, A. B., Pontes, B. B., Gioia, L. N., & Rangel, V. (2023) · EPITAYA eBooks · doi:10.47879/ed.ep.2023809p11
Renal denervation benefits in chronic kidney disease: An updated review
Habas, E. M., Alarbi, K. M. S., Habas, A. M., Baghi, M. A. M., Habas, E., Rayani, A., Said, A., Farfar, K., Errayes, A., Alfitori, G. B., et al. (2024) · Yemen Journal of Medicine · doi:10.18231/j.yjom.2024.004
Yao, Y., Zhang, X., Ye, R., Jia, S., Yang, X., & Chen, X. (2025) · Trials · doi:10.1186/s13063-025-08719-8
Abuelsoud, N. N., & Abdelraouf, F. H. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00124
Wasiliew, S., Lipski, D., Stryczyński, Ł., Radziemski, A., Królak, J., Tykarski, A., & Uruski, P. (2025) · Artery Research · doi:10.1007/s44200-025-00095-7
Particularidades de la hipertensión arterial en el paciente con enfermedad renal crónica
Montejo-Hernández, J. D., Ariza, A., Puello, L., & Bendek, I. V. (2025) · Revista Colombiana de Nefrología · doi:10.22265/acnef.12.3.918
Селезнев, С. В., Shchulkin, A. V., Yakusheva, E. N., Yakushin, S. S., Mylnikov, P. Y., Nikulina, N., Abalenikhina, Y. V., & MZHAVANADZE, N. D. (2025) · I P Pavlov Russian Medical Biological Herald · doi:10.17816/pavlovj693157
Akinboboye, A. C., Manafa, C. C., Odukale-Okuneye, A. O., Ariahu, N., & Adesoye, I. M. (2026) · Cureus · doi:10.7759/cureus.101291
Practical Prescribing: Potassium sparing diuretics
Anisman, S. D., Erickson, S. B., & Luneau, A. K. (2026) · BMJ · doi:10.1136/bmj-2025-085905
Matova, O. O., Mishchenko, L. A., & Кучменко, О. Б. (2026) · HYPERTENSION · doi:10.22141/2224-1485.18.3-4.2025.385
Progress in the Synthesis and Biological Studies of S -1-Propenyl -L- cysteine from Garlic
Lingyan, T., Shoufeng, W., & Wei, Z. (2026) · Chinese Journal of Organic Chemistry · doi:10.6023/cjoc202505028
Chen, X., Tong, C., Wang, J., Wu, Y., Feng, T., Wang, J., Gong, Z., Chen, Y., Chen, S., Jin, X., et al. (2026) · Cardiology Research and Practice · doi:10.1155/crp/5582480
da Costa, B. V. P. L., de Bulhões, F. V., Macedo, C., Caria, A. C. I., & Aras, R. (2026) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250627
Hypertension artérielle résistante et maladie rénale chronique : déterminants et risques associés
Kaboré, J. (2016) · theses.fr (ABES) · doi:10.70675/28f5ed83z9110z4f85z8b0fz6ea4e8d0aaae
Селезнев, С. В., Shchulkin, A. V., Mylnikov, P. Y., & Yаkushin, S. S. (2026) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2026-2526
Prevalence of Obstructive Sleep Apnea Syndrome in Patients with Resistant Hypertension
Özyurt, S., Taştan, M., Gümüş, A., Polat, H. B., & Özçelik, N. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15082894
Tsai, C., Chang, Y., Chang, C. C., Chang, Y., Chen, U.-L., Chueh, S., Brown, J. M., Wu, V., Lin, Y., & Vaidya, A. (2026) · medRxiv · doi:10.64898/2026.05.16.26353384
Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension
Shankar, B., Ben-Shlomo, A., Cheng, S. C., & Ebinger, J. E. (2026) · Current Hypertension Reports · doi:10.1007/s11906-026-01371-w
Kamrul-Hasan, A. B. M., Chatterjee, S., Nagendra, L., Nair, S., Dutta, D., & Pappachan, J. M. (2026) · Medicine · doi:10.1097/md.0000000000049158
Lee, Y. R., Park, M., Cho, Y. S., & Park, H. (2026) · International Journal of Hypertension · doi:10.1155/ijhy/9656975
Resistant Hypertension in Chronic Kidney Disease
Mallamaci, F., & Tripepi, G. (2026) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-032-29564-4_14
Perceptions and practices of primary care physicians in the management of resistant hypertension
Wong, C. W. K., Lee, R., Lee, J., Leong, E. K. F., Ramani, N. V., Tan, N. C., Puar, T. H. K., & Parameswaran, R. (2026) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2025-248
Gadelmawla, A. F., Hageen, A. W., Rateb, R. M., Diaa, A., Atta, K., Alsubaiei, A. A., AlSejari, N., Artam, A. S., Awashra, A., Warasna, H. J. M., et al. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001427
Danielli, M., & Munroe, P. B. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.27554
Martin, R., Palomo‐Piñón, S., Alcocer, L., Galván‐Oseguera, H., Chávez‐Mendoza, A., Muñoz, E. G. C., Álvarez‐López, H., Enciso‐Muñoz, J. M., Díaz‐Díaz, E., & GREHTA Group (2026) · Annals of Clinical Hypertension · doi:10.29328/journal.ach.1001046
Abu-Zahra, T., Grimm, S. E., Scholte, M., Casas, A. I., Saliba‐Gustafsson, P., Parini, P., & Joore, M. A. (2026) · Applied Health Economics and Health Policy · doi:10.1007/s40258-026-01075-x
Anyfanti, P., Antza, C., Korki, E., Aintinidou, E., Papadopoulos, K., Angeloudi, E., & Kotsis, V. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2745393
Kang, J., Solages, N., Samico, G., Gutkind, N. E., Scherer, R., Medeiros, F., & Swaminathan, S. S. (2026) · medRxiv · doi:10.64898/2026.10.29.26366154
Shamshilina, V. A., Blinova, N. V., Тиграновна, Х. Н., Анатольевна, С. О., & Chazova, I. E. (2026) · Systemic Hypertension · doi:10.38109/2075-082x-2026-3-49-59
Metadata
- Authors
- Sim, J. J., Bhandari, S. K., Shi, J., Reynolds, K., Calhoun, D. A., Kalantar-Zadeh, K., & Jacobsen, S. J.
- Affiliations
- Kaiser Permanente (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Sim, John J.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 88
- Issue
- 3
- Pages
- 622-632
- ISSN
- 0085-2538 (ISSN-L)
- PMC
- PMC4556588
- OpenAlex
- W1544563963
- Cited by
- 238
- References
- 55
- Citations by year
- 2026: 29 · 2025: 23 · 2024: 23 · 2023: 29 · 2022: 22 · 2021: 18 · 2020: 27 · 2019: 16 · 2018: 18 · 2017: 16 · 2016: 11 · 2015: 4
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Kaiser Permanente
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK091419)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- resistant hypertension, uncontrolled hypertension, controlled hypertension, end-stage renal disease, congestive heart failure, stroke, all-cause mortality, cardiovascular risk, sex differences, Hispanic origin, chronic kidney disease
- MeSH terms
- Aged, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Cerebrovascular Disorders, Drug Resistance, Female, Heart Failure, Humans, Hypertension, Kidney Failure, Chronic, Male, Middle Aged, Retrospective Studies, Risk Factors, Time Factors, Multivariate Analysis, Chi-Square Distribution, Proportional Hazards Models, Treatment Outcome, Myocardial Ischemia, Risk Assessment, Disease-Free Survival, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
